Fisher & Paykel Healthcare Co Ltd 2023 AR2
The report outlines Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended March 31, 2023. The company achieved operating revenue of NZ$1.58 billion and treated approximately 20 million patients globally. Key sustainability highlights include the commissioning of a new water re-use plant and a solar array at its Tijuana, Mexico manufacturing site. Additionally, the company progressed its commitment to reduce Scope 1 and 2 emissions by 67% by 2034, aligning with a long-term pathway to net zero by 2050.
Company: Fisher & Paykel Healthcare Co Ltd
Sector: Manufacturing
Country: New Zealand
Year: 2023
Type: AR2
Pages: 156
Back to company
Fisher & Paykel Healthcare Co Ltd
Annual Report
The report outlines Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended March 31, 2023. The company achieved operating revenue of NZ$1.58 billion and treated approximately 20 million patients globally. Key sustainability highlights include the commissioning of a new water re-use plant and a solar array at its Tijuana, Mexico manufacturing site. Additionally, the company progressed its commitment to reduce Scope 1 and 2 emissions by 67% by 2034, aligning with a long-term pathway to net zero by 2050.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Published
May 25, 2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees